ARCHIVES

Concepts Approved For Developmental Therapeutics Program

This article is from The Cancer Letter archive.

Vol. 13 No. 25 | June 19, 1987

Download PDF Visit The Full Archive

Related Articles

NIH Expands Minority Biomedical Research Training

July 11, 1975

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Another Potti Paper Retracted

September 16, 2011

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

New CIS Regions Draw Support, Some Objections

July 5, 1991